Lupus nephritis (LN) is a form of glomerulonephritis that constitutes one of the most severe organ manifestations of the autoimmune disease systemic lupus erythematosus (SLE). Most patients with SLE who develop LN do so within 5 years of an SLE diagnosis and, in many cases, LN is the presenting manifestation resulting in the diagnosis of SLE ...
Ramesh Saxena +2 more
exaly +7 more sources
Evaluation of Urinary Ceruloplasmin as a Novel Biomarker for Lupus Nephritis [PDF]
Background: A crucial step in modifying the course of lupus nephritis is the early identification of kidney disease in systemic lupus patients. Lupus nephritis affects around 30% to 60% of SLE patients and 70% of juvenile SLE.
Muhammad Harb +3 more
doaj +1 more source
The Relation between Plasma Complement 4 d and Lupus Nephritis at Zagazig University Hospitals [PDF]
Lupus nephritis is a common and serious manifestation of systemic lupus erythematosus,its diagnosis is established by a combination of clinical ,laboratory, serological data and histology of the kidney.
Sara Sakr +3 more
doaj +1 more source
A study on the relationship between morphological lesions of lupus nephritis with demographic and biochemical findings [PDF]
Introduction: Lupus nephritis is one of the important aspects of systemic lupus erythematosus (SLE). Objectives: This study aimed to investigate possible relationship between pathological lesions of lupus nephritis classes and demographic and biochemical
Nasrin Tavassoli +2 more
doaj +1 more source
Increase in direct costs for health systems due to lupus nephritis: the case of Colombia
Objective Lupus nephritis is one of the most severe complications of systemic lupus erythematosus and it has been estimated that can occur in up to 60% of patients. Direct costs of lupus nephritis have not been studied in developing countries.
Sergio I Prada +3 more
doaj +1 more source
Novel Therapeutics for Management of Lupus Nephritis: What Is Next?
Lupus nephritis is a severe, organ-threatening manifestation of systemic lupus erythematosus. The current standard of care in the treatment of lupus nephritis is limited to broad-spectrum immunosuppressants, which have significant concerns of short- and ...
Sayali B. Thakare +5 more
doaj +1 more source
Interleukin-17 expression positively correlates with disease severity of lupus nephritis by increasing anti-double-stranded DNA antibody production in a lupus model induced by activated lymphocyte derived DNA. [PDF]
Lupus nephritis is one of the most serious manifestations and one of the strongest predictors of a poor outcome in systemic lupus erythematosus (SLE).
Zhenke Wen +5 more
doaj +1 more source
Comparison of clinical features and outcomes between patients with early and delayed lupus nephritis
Background Lupus nephritis is associated with increased risk of end-stage renal disease (ESRD) and all-cause mortality. We evaluated the clinical features and outcomes of patients with early and delayed lupus nephritis. Methods The medical records of 171
Sung Soo Ahn +5 more
doaj +1 more source
Lupus nephritis is one of the more serious manifestations of the systemic autoimmune disease, systemic lupus erythematosus, and is associated with considerable morbidity and even mortality. Treatment remains problematic, particularly in terms of controlling the underlying disease process while at the same time preventing unacceptable side effects of ...
Neerja, Agrawal +2 more
openaire +4 more sources
Lupus nephritis is one of the most common and serious complications of systemic lupus erythematosus, attributed to increased morbidity and mortality. The in situ deposition of intrarenal immune complexes promote the accumulation of inflammatory cells and
Samy Hakroush +2 more
doaj +1 more source

